Endocrinology

Top Story

DKA common after bariatric surgery in high-risk patients with type 1 diabetes, obesity

DKA common after bariatric surgery in high-risk patients with type 1 diabetes, obesity
February 11, 2016

Patients with type 1 diabetes, obesity and poor glycemic control undergoing bariatric surgery are at risk for developing diabetic ketoacidosis, particularly those experiencing postoperative infection, prolonged poor oral intake and severe dehydration, according to recent findings.

Ali Aminian, MD, bariatric surgeon at Cleveland Clinic's Digestive Disease Institute, and colleagues analyzed data from 12 patients who developed diabetic ketoacidosis (DKA) within 90 days after bariatric surgery at an academic center between 2005 and 2015 (10 women; mean age, 49 years; mean preoperative BMI, 43.1 kg/m²; eight with type 1 diabetes).

In the Journals

Self-reported Agent Orange exposure higher among veterans with thyroid cancer

February 11, 2016
Self-reported Agent Orange exposure was more prevalent among patients with thyroid cancer compared with the overall national Veterans Affairs patient population, study…
In the Journals

Hyperthyroidism increases breast cancer risk

February 11, 2016
Women with hyperthyroidism have an increased risk for breast cancer, whereas there was a slightly decreased risk among women with hypothyroidism, according to study…
In the Journals

WHI: Sodium intake unlikely to affect osteoporosis risk in postmenopausal women

February 11, 2016
Sodium intake that falls within the current guidelines does not significantly affect the risk for osteoporosis in postmenopausal women, according to an analysis of…
Breaking News

Doctors urge Congress to preserve the 340B Drug Pricing Program

February 11, 2016
Thousands of physicians from American safety-net hospitals signed a letter sent to Congress highlighting the importance of the 340B Drug Pricing Program.The letter asks…
More News Headlines »
CME

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Meeting News CoverageVideo

VIDEO: Exercise, clinician support necessary for patients with fatty liver

November 14, 2015
More »
Featured
CME

Managing Obesity in 2015: Setting the Framework and Assessing All of the Options

This activity is supported by an educational grant from Novo Nordisk.

This CME activity is based on the slides and lectures presented by the faculty at the symposium, Managing Obesity in…
More »
Current Issues
View the Current Issues
morganatic-roan morganatic-roan